HAVCR2 binds LGALS9

Stable Identifier
R-HSA-5340385
Type
Reaction [binding]
Species
Homo sapiens
Compartment
Locations in the PathwayBrowser
General
SVG |   | PPTX  | SBGN
Click the image above or here to open this reaction in the Pathway Browser
The layout of this reaction may differ from that in the pathway view due to the constraints in pathway layout

T-helper (Th) cell-mediated immunity is required to eliminate pathogens effectively but unrestrained Th activity can contribute to tissue damage in many inflammatory and autoimmune diseases. The T-cell immunoglobulin and mucin domain-containing protein (HAVCR2, TIM3) inhibits T-helper type 1 lymphocyte (Th1)-mediated auto- and allo-immune responses and promotes immunological tolerance when it binds to its ligand, galectin-9 (LGALS9). The HAVCR2:LGALS9 complex achieves this inhibition by inducing apoptosis of Th1 cells. The human event is inferred from experimental data from mouse studies (Sanchez-Fueyo et al. 2003, Zhu et al. 2005).

Literature References
PubMed ID Title Journal Year
16286920 The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity

Zhu, C, Anderson, AC, Schubart, A, Xiong, H, Imitola, J, Khoury, SJ, Zheng, XX, Strom, TB, Kuchroo, VK

Nat. Immunol. 2005
14556005 Tim-3 inhibits T helper type 1-mediated auto- and alloimmune responses and promotes immunological tolerance

Sánchez-Fueyo, A, Tian, J, Picarella, D, Domenig, C, Zheng, XX, Sabatos, CA, Manlongat, N, Bender, O, Kamradt, T, Kuchroo, VK, Gutiérrez-Ramos, JC, Coyle, AJ, Strom, TB

Nat. Immunol. 2003
Participants
Participant Of
Inferred From
Authored
Reviewed
Created
Cite Us!